Dinsmore Capital Management’s Pfizer PFE Stock Holding History

Dinsmore Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.26M	Hold	42,160	–	–	0.55%	90
2015 Q2	$1.34M	Hold	42,160	–	–	0.53%	87
2015 Q1	$1.39M	Hold	42,160	–	–	0.55%	87
2014 Q4	$1.25M	Hold	42,160	–	–	0.49%	92
2014 Q3	$1.19M	Hold	42,160	–	–	0.47%	95
2014 Q2	$1.19M	Hold	42,160	–	–	0.46%	96
2014 Q1	$1.28M	Hold	42,160	–	–	0.51%	89
2013 Q4	$1.23M	Hold	42,160	–	–	0.5%	90
2013 Q3	$1.15M	Hold	42,160	–	–	0.48%	97
2013 Q2	$1.12M	Buy	+42,160	New	+$1.16M	0.49%	93

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dinsmore Capital Management's PFE Position: Q3 2015 in Review

Dinsmore Capital Management held its Pfizer (PFE) position steady in Q3 2015 at 42,160 shares worth $1.26M. The position accounts for 0.55% of the portfolio, ranked #90.

Dinsmore Capital Management first reported a position in PFE in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.39M in Q1 2015. 1,880 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

Dinsmore Capital Management held 42,160 shares of Pfizer worth $1.26M as of Q3 2015.
Dinsmore Capital Management left its Pfizer share count unchanged in Q3 2015.
Pfizer made up 0.55% of Dinsmore Capital Management's portfolio in Q3 2015, its #90 holding.
Dinsmore Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 10 quarters since.
Dinsmore Capital Management's Pfizer position peaked at $1.39M in Q1 2015.
1,880 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Dinsmore Capital Management's 13F filing for Q3 2015, filed 20 Oct 2015.